Indeed, CD56dimNKG2A+ NK cells from the peripheral blood of HFRS patients displayed stronger activation, higher levels of TNF-α production and degranulation ability under the treatment of HLA-E/HTNV-NP5 peptide, especially when compared with CD56dimNKG2A- NK cells. The gene discussed is HLA-E; the disease is hemorrhagic fever with renal syndrome.